Press Releases

LOS ANGELES, Aug. 9, 2019 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing in oncology and rare diseases, today announced financial results for the second quarter ended June 30, 2019, and provided an overview of recent accomplishments.

WATERTOWN, Mass., Aug. 9, 2019 /PRNewswire/ -- Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S ("ALK") to commercialize the company's epinephrine autoinjector (EAI) for the treatment of anaphylactic shock. Under its agreement with Windgap, ALK has exclusive, worldwide sales and distribution rights for the Windga

ROCHESTER, N.Y., Aug. 9, 2019 /PRNewswire/ -- Unity Hospital, part of Rochester Regional Health, is the first hospital in New York State to offer the 7D Surgical System for spine and cranial procedures. Now, surgeons at Unity are assisted by a fast and radiation-free tool that provides real-time 3D images using machine-vision

The Company Has Retained The Services Of Duff & Phelps Canada Limited, An Independent Valuation Firm, To Conduct A Full Valuation Of Company's Current Assets TORONTO, Aug. 8, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL (OTCPK:SOLCF) ) (Frankfurt:9SB), is pleased to announce tod

COLUMBIA, Md., Aug. 9, 2019 /PRNewswire/ -- Bioenergy DevCo, a leading global developer of anaerobic digestion facilities that create renewable energy and healthy soil products, announced today that it has acquired BTS Biogas, which will operate as an affiliate and enable new operation and expansion of anaerobic digestion in North America.  Headquartered in

SEATTLE, Aug. 9, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that H

FREMONT, Calif., Aug. 9, 2019 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment choices for people with cardiorenal diseases, today reported business highlights and financial results for the second quarter ended June 30, 2019.

SAN DIEGO and VANCOUVER, British Columbia, Aug. 9, 2019 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today reported

NASHVILLE, Tenn., Aug. 9, 2019 /PRNewswire/ -- Musicians On Call (MOC), a nonprofit that brings live and recorded music to the bedsides of patients

FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended June 30, 2019.  All comparisons, unless otherwise noted, are to the quarter ended June 30